Please assess the completion status of the following clinical trial:

Trial Title: Effects of Flourish HEC and BioGenesis to Improve Conception

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Women part of a cisgender couple aged 18 to 40 who are attempting to become pregnant and are attending a fertility clinic.~Exclusion Criteria:~1. Pregnant~2. Lactating~3. Severe male factor, hormonal imbalance (oligoovulatory/anovulatory cycles, cycles longer than 35 days), genetic abnormalities (chromosomal abnormality, common genetic mutation between partners), or severe uterine or tubal factor~4. Any diagnosis that would require the participant to undergo in vitro fertilization to become pregnant~5. Known allergies to any component of BioNourish®, Balance, BiopHresh®, or BioGenesis™~6. Known active vaginal infection at enrollment

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- Control arm (Type: NO_INTERVENTION): Women follow routine care only, including prescribed medications and recommended techniques and supplements for attempting to become pregnant at home for up to three months.
- Flourish HEC + BioGenesis arm (Type: EXPERIMENTAL): In addition to routine care followed by women in control arm, women in this arm also use the Flourish HEC (Hydroxyethylcellulose) vaginal care system and BioGenesis fertility lubricant for up to three months.

Based on this trial design, predict the completion outcome and termination type (if applicable).